e.g. Filippa Pettersson or Cancer Res. 75(6) , 1102-12, (2015) or 10.1002/anie.201600521
Development of CXCR3 antagonists. Part 3: Tropenyl and homotropenyl-piperidine urea derivatives
…, GA Chapman, FC Galvin, LA Jopling, RL Knight…
Index: Watson, Robert J.; Allen, Daniel R.; Birch, Helen L.; Chapman, Gayle A.; Galvin, Frances C.; Jopling, Louise A.; Knight, Roland L.; Meier, Dorica; Oliver, Kathryn; Meissner, Johannes W.G.; Owen, David A.; Thomas, Elizabeth J.; Tremayne, Neil; Williams, Sophie C. Bioorganic and Medicinal Chemistry Letters, 2008 , vol. 18, # 1 p. 147 - 151
The optimization of a series of 1-aryl-3-piperidinyl urea derivatives is described in which incorporation of tropenyl and homotropenyl moieties has led to significant improvements in activity and drug-like properties. Replacement of the central piperidine with an exo-tropanyl unit led to the identification of compound 15 which provides a combination of excellent potency against human and murine receptors, drug-like properties and pharmacokinetics, ...